Content
02/01/2024
Los Altos, CA USA
Artera
completed $20 million Venture Round funding. Investors include
Walden Catalyst Ventures, Prosperity7 Ventures, A&E Investment.
About
Our AI can prognosticate patient outcomes & personalize treatment in localized prostate cancer.
Five Phase III randomized trials were used to develop prognostic and predictive AI biomarkers.
Startup
Sector:
Healthcare
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
